Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
Di Costanzo F, Canaletti R, Sdrobolini A, Olmeo N, Luppi G, Pucci F, Cavicchi F, Gasperoni S, Rodinò C, Zironi S, Angiona S, Contu A. Di Costanzo F, et al. Among authors: olmeo n. Am J Clin Oncol. 2000 Jun;23(3):314-8. doi: 10.1097/00000421-200006000-00022. Am J Clin Oncol. 2000. PMID: 10857901 Clinical Trial.
Lonidamine in non-small-cell lung cancer: a phase II study.
Contu A, Olmeo NA, Pani P, Deriu A, Ortu S, Paga C. Contu A, et al. Among authors: olmeo na. Tumori. 1991 Feb 28;77(1):52-5. doi: 10.1177/030089169107700113. Tumori. 1991. PMID: 1850177 Clinical Trial.
Impact of interferon at induction chemotherapy and maintenance treatment for multiple myeloma. Preliminary results of a multicenter study by the Italian non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).
Capnist G, Vespignani M, Spriano M, Damasio E, Craviotto L, Rizzoli V, Contu A, Olmeo N, Tedeschi L, Fabris P, et al. Capnist G, et al. Among authors: olmeo n. Acta Oncol. 1994;33(5):527-9. doi: 10.3109/02841869409083930. Acta Oncol. 1994. PMID: 7522487 Clinical Trial.
Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapy.
Passalacqua R, Campione F, Caminiti C, Salvagni S, Barilli A, Bella M, Barni S, Barsanti G, Caffo O, Carlini P, Cinquemani G, Di Costanzo F, Giustini L, Labianca R, Mazzei A, Olmeo N, Paccagnella A, Toscano L, Cocconi G. Passalacqua R, et al. Among authors: olmeo n. Lancet. 1999 Apr 17;353(9161):1310-4. doi: 10.1016/S0140-6736(98)10253-2. Lancet. 1999. PMID: 10218529
BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling.
Palmieri G, Palomba G, Cossu A, Pisano M, Dedola MF, Sarobba MG, Farris A, Olmeo N, Contu A, Pasca A, Satta MP, Persico I, Carboni AA, Cossu-Rocca P, Contini M, Mangion J, Stratton MR, Tanda F. Palmieri G, et al. Among authors: olmeo n. Ann Oncol. 2002 Dec;13(12):1899-907. doi: 10.1093/annonc/mdf326. Ann Oncol. 2002. PMID: 12453858 Free article.
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer.
Venturini M, Bighin C, Monfardini S, Cappuzzo F, Olmeo N, Durando A, Puglisi F, Nicoletto O, Lambiase A, Del Mastro L. Venturini M, et al. Among authors: olmeo n. Breast Cancer Res Treat. 2006 Jan;95(1):45-53. doi: 10.1007/s10549-005-9030-x. Breast Cancer Res Treat. 2006. PMID: 16267615 Clinical Trial.
32 results